Where I see patients (3)
Selected research
-
Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.
Blood
-
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.
Transplantation and cellular therapy
-
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
Blood
Clinical trials
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Seve...
The median time to failure or death will be compared on the two arms using the log-rank test. Failure of IST is defined as the date that a second definitive therapy was recommended (BMT, second course of ATG) and failure of BMT de...
Recruiting
More about this study
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children,...
We will estimate the cumulative incidence of severe GVHD at 1-year post-HCT and corresponding 95% confidence interval among enrolled and eligible patients randomly assigned to either HAPLO or MUD arms who actually undergo HTC.
Recruiting
More about this studyContact me
Soothing the soul
Our music therapy program nurtures patients with bedside serenades, rap workshops and more.
Find out more